Issue 71, 2020

Magnetic resonance imaging of high-intensity focused ultrasound-stimulated drug release from a self-reporting core@shell nanoparticle platform

Abstract

We developed a theranostic approach exemplifying a concept called an “exchange method” that controls and “images” drug release from nanoparticles using magnetic resonance imaging-guided high-intensity focused ultrasound. The controllable amount of released drug and therapeutic efficacy can be self-reported by associated MRI contrast changes in solution and in cells.

Graphical abstract: Magnetic resonance imaging of high-intensity focused ultrasound-stimulated drug release from a self-reporting core@shell nanoparticle platform

Supplementary files

Article information

Article type
Communication
Submitted
03 May 2020
Accepted
24 Jul 2020
First published
24 Jul 2020

Chem. Commun., 2020,56, 10297-10300

Magnetic resonance imaging of high-intensity focused ultrasound-stimulated drug release from a self-reporting core@shell nanoparticle platform

C. Cheng, W. Chen, L. Zhang, H. H. Wu and J. I. Zink, Chem. Commun., 2020, 56, 10297 DOI: 10.1039/D0CC03179H

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements